Immune Cells & Fertility: New Link Discovered in Puberty & Hypogonadism

Recent research is shedding new light on the complex interplay between the immune system and reproductive health, specifically revealing a surprising connection between brain immune cells and the onset of puberty and fertility. A study led by researchers at the National Cancer Research Center (CNIO) in Spain has identified a role for microglia – resident immune cells in the brain – and the RANK protein in regulating the hypothalamic-pituitary-gonadal (HPG) axis, the central control system for reproductive function. This discovery could open new avenues for understanding and potentially treating conditions affecting fertility and hormonal development.

The Hypothalamic-Pituitary-Gonadal Axis: A Primer

The process of becoming fertile is initiated in the brain, within a region called the hypothalamus. Here, specialized neurons release a hormone that activates the pituitary gland, located at the base of the skull. The pituitary gland, in turn, releases other hormones that trigger the maturation of the gonads – the ovaries or testicles. This intricate cascade of hormonal signals is known as the hypothalamic-pituitary-gonadal (HPG) axis. Understanding the HPG axis is fundamental to understanding reproductive development and function.

Traditionally, this system was understood to be regulated primarily by neuronal signaling. However, the new research demonstrates that microglia and the RANK protein play a previously unrecognized role in modulating this process. The findings suggest a more integrated view of reproductive regulation, where the immune system actively participates in hormonal control.

Microglia and RANK: Unexpected Players in Fertility

The study, published in the journal Science, revealed that microglia regulate the function of gonadotropin-releasing hormone (GnRH) neurons – the key neurons that initiate the HPG axis. This regulation occurs through the expression of the RANK protein, which is also known for its role in bone remodeling and mammary gland function. GnRH neurons control the onset of puberty, gonadal development, and fertility.

Researchers found that suppressing RANK expression in animal models led to significant disruptions in reproductive function in both males and females. Animals lacking RANK either from birth or after having the protein removed before puberty exhibited reduced sex hormone levels and impaired gonadal function, a condition known as hypogonadism. In sexually mature animals, eliminating RANK resulted in infertility within a month. These results underscore the critical role of RANK in maintaining normal reproductive function.

Visually, the research team observed that microglia “engulf” fragments of GnRH neurons in areas of interaction, particularly in animals without the RANK protein. This suggests a dynamic relationship where microglia actively influence the activity and potentially the survival of these crucial reproductive neurons.

Implications for Human Infertility and Congenital Conditions

To explore the relevance of these findings to human health, the researchers analyzed samples from patients with congenital hypogonadotropic hypogonadism (CHH), a rare genetic disorder characterized by delayed or absent puberty and infertility. They identified mutations in the gene encoding the RANK protein in some of these patients. This discovery suggests that RANK mutations could be a contributing factor to CHH in certain individuals.

“These results show that RANK could be a therapeutic target for endocrine alterations and syndromes that affect fertility, and also a candidate gene for the molecular diagnosis of congenital hypogonadotropic hypogonadism,” the study authors stated. This opens the possibility of developing targeted therapies to address fertility issues linked to RANK dysfunction.

Beyond Reproduction: A Broader Role for Microglia?

The study’s lead researcher, Eva González-Suárez, emphasizes the broader implications of these findings. “The role of microglia as a regulator of ‘reproducer’ neuron function is new, and that regulation associated with RANK may occur in other axes, for other functions, such as those of the appetite-satiety axis, the stress axis, etc.” This suggests that microglia and RANK may be involved in regulating a wide range of physiological processes beyond reproduction.

This research highlights the growing recognition of the intricate connection between the immune system and the brain, and its influence on hormonal regulation. It challenges the traditional view of the HPG axis as solely a neuronal circuit and suggests a more complex interplay between neurons and immune cells.

The Collaborative Nature of Scientific Discovery

The success of this research was built on a collaborative effort involving researchers from multiple institutions and disciplines. The team emphasized the importance of bringing together expertise in immunology, endocrinology, and neuroscience to tackle complex biological questions. This interdisciplinary approach allowed them to uncover unexpected connections and gain a deeper understanding of the underlying mechanisms regulating fertility.

The research team included members from the National Cancer Research Center (CNIO) in Spain, the University of Córdoba, the Institute Maimónides of Biomedical Research of Córdoba (IMIBIC), the Inserm (French National Institute of Health and Medical Research), the Institute of Biomedicine of Seville (IbiS), and the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland.

What’s Next: Further Research and Potential Therapies

Further research is needed to fully elucidate the mechanisms by which microglia and RANK regulate the HPG axis and to explore the potential for therapeutic interventions. Future studies will likely focus on investigating the specific signaling pathways involved and identifying other immune factors that may contribute to reproductive function. Understanding the physiology of the HPG axis is crucial for developing effective treatments for infertility and hormonal disorders. Researchers are also exploring the possibility of developing targeted therapies that modulate RANK activity to restore reproductive function in individuals with CHH or other fertility issues.